November 16, 2026 at 12:11 PM UTC
8-K - Prelude Therapeutics Inc (0001678660) (Filer)
Filed: 2026-11-16 AccNo: 0001193125-26-462029 Size: 21 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Official source: U.S. Securities and Exchange Commission
Official source published: November 16, 2026 at 12:09 PM UTC
Open official source